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A B S T R AC T
Tularemia is a zoonosis caused by different subspecies of 
the Gram-negative bacterium Francisella tularensis. We 
report the first case in the Netherlands of pneumonic 
tularemia caused by the F. tularensis subspecies holarctica 
after probable occupational inhalation of contaminated 
aerosols. Notification of cases of tularemia has been 
mandatory by law in the Netherlands since 1 November 
2016.
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I N T RODUC T I ON
Francisella tularensis is a Gram-negative intracellular 
coccobacillus causing tularemia, a bacterial zoonotic 
disease occurring throughout the northern hemisphere. 
It has been classified as a potential bioterrorism agent due 
to its highly infectious and virulent properties. Typically, 
F. tularensis subspecies tularensis (type A) strains are 
found in North America and can cause severe systemic 
disease. By contrast, F. tularensis subspecies holartica (type 
B), which is found throughout the northern hemisphere 
including in Europe, is associated with mild clinical 
manifestations.1 In the Netherlands, tularemia re-emerged 
in 2011.2-4 We report the first case of severe pneumonia 
What was known on this topic?
The clinical manifestations of tularemia vary 
according to the geographical distribution of 
subspecies and the site of inoculation. Typically, 
Francisella tularensis subspecies tularensis (type 
A) is associated with a case fatality of up to 
30% in Northern America, whereas F. tularensis 
subspecies holarctica (type B) generally causes 
mild to moderate symptoms. Until now, only 
ulceroglandular manifestations through direct 
transmission from infected hares or through 
arthropod bites have been seen in the Netherlands.
What does this add? 
After being absent in the Netherlands for nearly 
six decades, tularemia re-emerged in humans and 
animals in 2011. This case demonstrates that type 
B tularemia can cause severe pneumonic disease 
following inhalation of contaminated aerosols. 
To raise awareness and in order to gain a better 
insight into the reservoirs and possible routes of 
transmission, tularemia has recently become a 
notifiable disease in the Netherlands.
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caused by F. tularensis subspecies holartica (type B) in an 
immunocompetent patient in the Netherlands.
C A SE  R E P OR T
A 54-year-old previously healthy gardener was hospitalised 
after 1 week of progressive influenza-like symptoms 
including myalgia, fever and a non-productive cough. 
Physical examination revealed a pulse rate of 90/min, 
blood pressure of 130/80 mmHg, temperature of 39 °C 
and oxygen saturation of 88% while breathing ambient 
air. Breath sounds over the right lung were diminished. 
Skin and lymph node evaluation produced no abnormal 
findings. A chest X-ray showed consolidation of the 
right lower lobe, pleural effusion and a prominent hilus 
on the right side. Intravenous antibiotic therapy for 
community acquired pneumonia with penicillin and 
ciprofloxacin was started. Sputum PCR was negative 
for Legionella pneumophila, Chlamydia pneumoniae 
and Mycoplasma pneumoniae; empirical ciprofloxacin 
treatment was subsequently stopped. Routine blood and 
sputum cultures failed to detect a bacterial pathogen. 
After a few days, the patient’s dyspnoea worsened due to 
increasing pleural effusion. A computed tomography (CT) 
scan of the chest showed expansion of the infiltrate, pleural 
effusion and hilar and mediastinal lymphadenopathy 
with central necrosis (figure 1). Pleural fluid was obtained 
and the Gram stain revealed no bacteria. After 4 days, 
Gram-negative coccobacilli were cultured on chocolate 
agar from the pleural fluid, which the Maldi-ToF MS 
identified as F. tularensis. Subspecies-specific PCR of the 
cultured strain confirmed subspecies holarctica (type B). 
Antibiotics were switched to gentamicin and ciprofloxacin. 
A chest drain was inserted for drainage and administration 
of intrapleural fibrinolytics until culture results were 
negative. Ciprofloxacin monotherapy was continued for 
8 weeks until the patient fully recovered. Assessment of 
potential exposures to tularemia revealed that the patient 
had been mowing grass in a greenhouse 3 days before the 
onset of symptoms. F. tularensis could not be isolated from 
environmental cultures obtained from the greenhouse.
D I S CUS S I ON
We report the first case in the Netherlands of pneumonic 
tularemia caused by F. tularensis subspecies holarctica 
in an immunocompetent patient after lawn-mowing. 
This case report illustrates that F. tularensis subspecies 
holartica (type B) infection, typically associated with low 
virulence, can cause severe pneumonia with empyema 
and necrotising lymphadenitis, and may pose a rare 
occupational hazard in immunocompetent adults following 
inhalation of contaminated aerosols. Previous studies 
report pneumonic tularemia caused by type B F. tularensis 
mainly in immunocompromised patients.1,5-8 One study 
from Spain describes a cavitary pneumonia due to 
tularemia in a person without any medical history.9 
Although the subspecies is not mentioned in this case 
report, it is assumed to be a holartica strain due to the 
geographical location.
Tularemia can be transmitted via direct contact with 
infected animals (i.e. in hunters), arthropod bites, and 
by ingestion or inhalation. Small rodents, typically hares 
and rabbits, are considered the key animal reservoir of 
F. tularensis, yet mosquitoes, ticks, and contaminated 
water or soil are also regarded as a source of human 
infection. Different clinical manifestations of tularemia 
are recognised, depending on the portal of entry of 
bacteria.1,10,11 The ulceroglandular form is most common 
and combines an inoculation ulcer with regional 
lymphadenopathy. The oropharyngeal and oculoglandular 
forms occur after oral or conjunctival contamination, 
respectively. Pneumonic tularemia follows inhalation of 
contaminated aerosols. Finally, typhoidal tularemia is a 
severe systemic disease, irrespective of the portal of entry 
of bacteria, with high fever and neurological symptoms. 
The pneumonic and typhoidal forms of tularemia are 
rare in Europe.1 Tularemia is endemic in a few European 
countries including in Scandinavia, where it primarily 
causes the ulceroglandular form.12
Figure 1. Axial CT images demonstrating 
mediastinal lymphadenopathy (A, arrows), a hilar 
mass (B), a lobular infiltrate (C) in the right lower 
lobe and pleural effusion (D). Note the hypodense 
center of lymphadenopathy  (A and B), suggesting 
central necrosis
303
S E P T EM B E R  2 0 17 ,  V O L .  7 5 ,  N O .  7
The Netherlands Journal of Medicine
Sigaloff et al. Severe pneumonic tularemia in an immunocompetent patient.
Pneumonic tularemia has been nicknamed lawn mower’s 
disease and was studied during an outbreak in Martha’s 
Vineyard (Massachusetts, USA).13 This case-control study 
identified lawn mowing and brush cutting as the main 
risk factors for disease. This implies that F. tularensis can 
persist in the environment and can infect people after 
being mechanically aerosolised and inhaled. Another 
outbreak of airborne tularemia was described in Germany, 
where participants in a hare hunt became infected 
after rinsing disembowelled hares with a water hose.14 
Clinicians should consider the possibility of tularemia in 
patients with fever or pneumonia after specific (sometimes 
occupational) activities that can aerosolise the organism 
from the environment. However, pneumonic tularemia 
does not only occur after inhalation; it can also follow the 
ulceroglandular or typhoidal form of disease. The presence 
of cutaneous manifestations can differentiate between 
potential routes of transmission.
The treatment of tularemia depends on the causative 
subspecies. In North America, for infections with F. 
tularensis subspecies tularensis, aminoglycosides are the 
antibiotics of choice, followed by doxycycline for less severe 
cases. In Europe, treatment is often with ciprofloxacin.1 
In our patient, the clinical condition deteriorated after 
ciprofloxacin, which was included in the initial regimen, 
was stopped. After the diagnosis of pneumonic tularemia 
was made, ciprofloxacin was re-started and gentamicin was 
added, which is recommended in case of systemic disease.1 
Because relapses are described, the duration of antibiotic 
treatment is often prolonged. In cases with purulent 
lymphadenitis or empyema there are reports of surgical 
intervention to reduce the chance of relapse.7
After being absent in the Netherlands for almost six 
decades, tularemia has re-emerged in humans and hares. 
Since 2011 there have been ten reports of autochthonous 
human infection, of which four in 2016.15-17 Until now, 
other reported cases had ulceroglandular manifestations 
either through direct transmission from handling infected 
hares or through arthropod bites, and possibly through 
contaminated water or soil. We suspect that our patient 
contracted tularemia through occupational exposure while 
lawn mowing in a contaminated area without a protective 
mask. From November 2016 onwards, clinicians and 
laboratories are obliged to report all tularemia patients 
to the local health authorities. This notification and 
consecutive source tracing will contribute to a better 
understanding of the burden of disease, the role of existing 
reservoirs in animals, arthropods and environment, 
and possible routes of transmission. This information 
is essential in order to develop effective public health 
interventions to prevent future infections. Given its rarity, 
clinical suspicion of tularemia in patients with pneumonia 
is likely to remain low. However, clinicians should be 
aware of tularemia, especially in case of specific exposures 
or failure of empiric antibiotic therapy.
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